Form 4: VolitionRx Director Boosts Stake in Company

VolitionRx Director Guy Archibald Innes acquired 78,125 shares of common stock at $0.64 per share in a registered direct offering.

Summary

• Director Guy Archibald Innes of VolitionRx Ltd. (VNRX) purchased 78,125 shares of common stock.
• The transaction occurred on August 5, 2025, at a price of $0.64 per share, totaling $50,000.
• The shares were acquired at the offering price in a registered direct offering by VolitionRx.
• Following this transaction, Guy Archibald Innes directly beneficially owns 966,814 shares of common stock.
• Indirect beneficial ownership includes 1,400,000 shares through The Innes Family Bare Trust 2023, 356,000 shares through The Dill Faulkes Educational Trust Limited, and 618,014 shares through his children.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to a director's significant purchase of company stock, especially as part of a direct offering, which signals strong insider confidence.

Positives

• A director's purchase of shares indicates strong confidence in the company's current valuation and future prospects.
• Participation in a registered direct offering by an insider signals belief in the capital raise's purpose and the company's strategic direction.

Future Outlook

This Form 4 filing does not provide specific forward-looking statements or guidance regarding the company's future performance or strategic plans.

Industry Context

Insider buying, particularly by a director, is generally viewed as a positive signal within the market, suggesting that those closest to the company believe its shares are undervalued or that significant positive developments are anticipated. This action is specific to VolitionRx and its director, Guy Archibald Innes.

Comparison to Industry Standards

• Not applicable as this filing reports an individual insider transaction, not company financial or operational results that can be directly compared to industry benchmarks or competitor performance.

Related Party Transactions

• The filing discloses indirect beneficial ownership through The Innes Family Bare Trust 2023 (for the benefit of his children) and The Dill Faulkes Educational Trust Limited (where the reporting person serves as a director and trustee, disclaiming beneficial ownership except for pecuniary interest).

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of the company's future performance and management's belief in its value.

Key Dates

Recommendation

A director's decision to purchase a substantial number of shares, particularly through a direct offering, is a strong vote of confidence in the company's prospects and valuation. This insider buying activity often precedes positive developments or reflects a belief that the stock is currently undervalued, making it an attractive entry point for investors.

Keywords

VolitionRx, VNRX, Insider Trading, Form 4, Stock Purchase, Director, Guy Archibald Innes, Equity, Securities, SEC Filing, Direct Offering